# A Study of LY900014 in a Medtronic Pump

> **NCT03760640** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 42 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** LY900014
- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT03760640
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-18
- **Primary completion:** 2019-10-07
- **Final completion:** 2019-10-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760640, "A Study of LY900014 in a Medtronic Pump". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03760640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*